That means while many people are excited about its potential, more research is needed to confirm long-term safety and effectiveness in humans
BPC-157 and TB-500 are not FDA-approved for human use, and their safety and effectiveness in women have not been established
Mechanism of Action Differences Understanding how BPC-157 and TB-500 promote healing reveals why researchers often consider them complementary rather than interchangeable
Specialized stable versions designed for oral use offer better survival through the gastrointestinal tract
Required materials: BPC 157 lyophilized vial (typically 5 mg or 10 mg) Bacteriostatic water (BAC water, 0.9% benzyl alcohol) for injection U-100 insulin syringes (1 mL capacity, 2831 gauge) Alcohol swabs (70% isopropyl) Sterile nitrile gloves A clean, flat workspace (ideally wiped with 70% isopropyl alcohol) Sharps disposal container Workspace and vial preparation: Warming the lyophilized vial to room temperature for 1020 minutes before opening reduces condensation on the stopper
That distinction is more important than most people realize because the Federal Food, Drug, and Cosmetic Act (FD&C Act) was designed to accomplish two important objectives
